Recently, the parallel forum of digital Life and Health Forum of the 2021 Global Digital Economy Conference – Digital New Country branch was successfully held online and offline. David Nelson, head of global Strategy and Market Development, Government Health and Human Services, IBM AI Healthcare, was invited to deliver a keynote speech entitled “Technology Driving Healthcare Innovation”.
David Nelson describes how IBM Project Alvearie addresses the common challenges of health data integration and interoperability through an online video based on innovative ideas and cases of technology driving healthcare. Using the IBMClinical Development (ICD) platform to support digital clinical trials during the pandemic; And how IBM Micromedex can help lead to evidence-based medicine in leading hospitals to support safe drug use; Medical institutions use AI platforms to analyze and process medical and health data, and patient-centered digital health passes based on blockchain technology to help companies return to work.
He said that ARTIFICIAL intelligence is a tool for understanding, reasoning, learning and communication. High-tech technologies represented by ARTIFICIAL intelligence, blockchain and big data analysis are changing the pattern of the world’s medical and health undertakings, empowering all segments of the medical and health sectors and promoting the high-quality innovation and development of the global medical and health undertakings.
The following is a summary of the speech
“Healthcare has always been a hot area for technological innovation. Healthcare is going through huge changes.” Global health, health and social services, and life science organizations are at a turning point — and health is changing particularly fast.
As testing and treatment technologies continue to advance, the global healthcare delivery system will continue to evolve. The past 18 months have seen an acceleration of new technological inventions, innovations, testing and adoption, creating rare opportunities to optimize and improve healthcare systems for the future. On this basis, stakeholders in the healthcare industry and governments around the world have recognized this and have increased their investment and support in technological innovation.
Now, all sectors of society are working to reduce the impact of COVID-19 in 2020, and to learn from it, build on it, and build on it for a better future. We also thought about how we could contribute to that process…
China has set ambitious goals and shown international leadership in technological innovation. For example, China plans to become one of the world leaders in artificial intelligence innovation by 2030. It is a recognition of the power of digital transformation and artificial intelligence for the future of all societies and humanity. Healthy China 2030 has become a bright vision in the medical and health sector. Make public health one of the essential elements of future economic and social development.
These efforts need to take into account certain social contexts. The needs of the global population are changing, global ageing is becoming more serious and health needs are more complex. Changing diseases, ecosystems and lifestyles add to the challenges of health care programs.
The pandemic has reshaped society’s view of medicine and health, and reshaped the role of technologies, including cloud computing, big data analytics and AI-driven workflows, in driving the digital transformation of health and social services.
The examples of health care innovation are endless. In today’s session, I’m going to share IBM’s perspective on big health on how technology is driving healthcare innovation.
Today’s sharing will focus specifically on: Information and interactive operating systems, cloud computing, edge computing, blockchain and ARTIFICIAL intelligence. Accelerating AI-powered scenarios and changing consumer and business expectations.
Hopefully, the examples shared today illustrate how better outcomes can be built around individuals, healthier populations, and better health systems.
Consumers want health information from smartwatches, phones and tablets. If augmented reality can help clinicians take care of their patients and consumers take care of their health at a time when there is a shortage of clinicians, it represents a once-in-a-lifetime opportunity. First, let’s look at interoperability.
First, information interoperability is the foundation of technological innovation
“Laying the groundwork with Interoperability and Open technologies”
Information interoperability is the foundation of technological innovation. Connecting information and systems, 360-degree insight into health systems is critical.
Innovation leaders also point to the importance of interoperability in social services. They believe that social determinants of health contribute to individual health. Research suggests that social determinants may be more important than health in influencing the health of populations… Studies have shown that it can affect health outcomes by 30-55%.
For a long-term vision of technical interoperability, innovation leaders are seeking to create network effects that are supported by apis and built on top of open hybrid cloud infrastructures. To serve all stakeholders in the healthcare system.
Depending on the country’s payment system, clinical information infrastructure, and vendor adoption of management systems — such as single-payer, or government-sponsored health systems — the situation may vary from country to country.
However, the principle is the same — stakeholders in healthcare and social services want an interoperable system that can fully understand the patient view and strive for the best results.
As a result, the healthcare IT industry is fundamentally changing the way applications are built and connected. A plethora of apis, formats, protocols, and other specific specifications are springing up to deliver on the promise of healthcare transformation. The driving force behind this is not only prompted by government regulators, but also by industry organizations.
Open standards to the platform — simplify system innovation and enable developers to benefit from a concerted effort to accelerate innovation.
Applying open standards to healthcare data can provide near real-time insights into care management for better results.
For example, as more organizations invest in rapid healthcare interoperability resources (now commonly referred to as FHIR), healthcare availability analysis is gaining ground. They are looking for new ideas to improve data quality and fill gaps in care. (See FHIR blog analysis)
“Health data connectivity to provide smarter processes, better care, faster breakthroughs, and a better consumer experience.”
IBM’s healthcare data connectivity initiative focuses on transforming healthcare systems to provide smarter processes, better care, faster breakthroughs, and a better consumer experience.
We call this cross-industry collaboration Project Alvearie to address a common smart healthcare challenge in health data integration and circulation. We hope this effort will enable organizations to better leverage health data analysis to optimize health solutions.
This example of cross-industry interoperability is consistent with IBM’s advocacy to leverage the benefits of open source in terms of extensibility and innovation.
The project focuses on how technologies can be combined into meaningful medical models. The project brings together several contributors from the healthcare and life sciences systems. Empower organizations to use data and analytical programs to help improve the quality of care and drive its more efficient operation. Of course, all this is aimed at working together for smart medicine and the optimization of health outcomes.
In terms of interoperable components, there are a number of open source projects such as IBM FHIR Server, Linux for Health, data delabeling, Health record acquisition, image data acquisition, Health pattern recognition and efficacy evaluation, and big data queuing services.
We work with many healthcare communities on open source projects to meet the needs of our customers and industry.
Second, digital transformation — to modernize enterprises and promote smart healthcare
In the life sciences, innovation can have a broad impact, including clinical trial design, drug interaction models and genetic correlations.
Here is an example of how IBM is working with the life sciences to use technology to respond quickly to the challenges of the pandemic:
In February 2020, IBM began making its IBM Clinical Development Platform (ICD) available free of charge to eligible clinical trial facilities to help drug and vaccine researchers respond to COVID-19. Over the next year, a number of pharmaceutical companies, CRO companies, and medical academic institutions worked with us. Currently 69 studies have been included in the programme.
In many cases, the speed with which these organizations conducted clinical trials using IBM’s platform was unexpected, demonstrating the benefits of leveraging technological innovation in the clinical trial community. To its credit, too, all this is happening at a particularly difficult time. For example, the global pandemic has disrupted more than a thousand clinical trials.
IBM is proud to support these organizations and others around the world. We have witnessed how researchers and Clinical trial data managers have successfully achieved significant acceleration using IBM Clinical Development.
IBM is also working with many organizations to help standardize and implement many of the new technologies that have been deployed during the pandemic, speeding up processes and minimizing costs to stand the test of time.
This case is a good example of how our company can help our clients overcome great challenges and become stronger.